Titre : | Medical marijuana's public health lessons - Implications for retail marijuana in Colorado (2015) |
Auteurs : | T. S. GHOSH ; M. VAN DYKE ; A. MAFFEY ; E. WHITLEY ; D. ERPELDING ; L. WOLK |
Type de document : | Article : Périodique |
Dans : | New England Journal of Medicine (Vol.372, n°11, March 12, 2015) |
Article en page(s) : | 991-993 |
Langues: | Anglais |
Discipline : | SAN (Santé publique / Public health) |
Mots-clés : |
Thésaurus géographique ETATS-UNISThésaurus mots-clés CANNABIS ; USAGE THERAPEUTIQUE ; SANTE PUBLIQUE ; VENTE ; LEGALISATION ; USAGE RECREATIF ; FACTEUR DE RISQUE |
Résumé : | In 2000, Colorado residents voted to legalize marijuana use for medical conditions such as glaucoma, HIV?AIDS, cancer, seizures, and severe pain. From 2000 to 2009, medical marijuana was available in Colorado only from plants grown in noncommercial, home settings, and the number of medical users or registrants remained relatively small. But in 2010, state law was changed to permit commercial production and distribution of medical marijuana. The number of registrants (both adults and children) grew rapidly - from 4819 in December 2008 to 115,467 in December 2014 - and medical-marijuana dispensaries proliferated. Then, on January 1, 2014, Colorado became the first U.S. state to allow sales of recreational, or retail, marijuana. With no state models or national guidance to follow, Colorado public health officials have turned to lessons from medical marijuana to prepare for the potential public health implications of more widely available recreational marijuana. [Extract] |
Domaine : | Drogues illicites / Illicit drugs |
Refs biblio. : | 5 |
Affiliation : | Colorado Department of Public Health and Environment, Denver, CO, USA |
Lien : | http://dx.doi.org/10.1056/NEJMp1500043 |
Accueil